---
author:
  - name: Reuters
    url: 'http://www.medicaldaily.com/user/894'
    avatar: {}
related: []
publisher:
  url: 'http://www.medicaldaily.com'
  name: Medical Daily
  favicon: 'http://images.medicaldaily.com/sites/medicaldaily.com/themes/medicaldaily/favicon.ico'
  domain: www.medicaldaily.com
keywords:
  - epidiolex
  - epilepsy
  - trial
  - gover
  - drug
  - cannabis
  - iii
  - dravet
  - phase
  - cannabinoids
description: 'LONDON (Reuters) - An experimental cannabis-based drug has successfully treated children with a rare form of severe epilepsy in a keenly anticipated clinical trial, more than doubling the value of its maker GW Pharmaceuticals.'
inLanguage: en
app_links: []
isBasedOnUrl: 'http://www.medicaldaily.com/cannabis-drug-succeeds-epilepsy-377788'
title: 'Cannabis Drug Succeeds In Epilepsy, Doubling Value Of GW Pharma'
datePublished: '2016-03-19T12:48:10.691Z'
dateModified: '2016-03-19T12:42:35.521Z'
sourcePath: _posts/2016-03-19-cannabis-drug-succeeds-in-epilepsy-doubling-value-of-gw-pha.md
published: true
inFeed: true
hasPage: false
inNav: false
_context: 'http://schema.org'
_type: MediaObject

---
<article style=""><h1>Cannabis Drug Succeeds In Epilepsy, Doubling Value Of GW Pharma</h1><p>LONDON (Reuters) - An experimental cannabis-based drug has successfully treated children with a rare form of severe epilepsy in a keenly anticipated clinical trial, more than doubling the value of its maker GW Pharmaceuticals.</p><img src="http://images.medicaldaily.com/sites/medicaldaily.com/files/styles/headline/public/2016/03/14/cannabis.JPG" /></article>